PhiChem Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Robin Su

Chief executive officer

CN¥2.7m

Total compensation

CEO salary percentage	n/a
CEO tenure	4yrs
CEO ownership	0.1%
Management average tenure	4.6yrs
Board average tenure	1.1yrs

Recent management updates

Recent updates

PhiChem Corporation (SZSE:300398) Might Not Be As Mispriced As It Looks After Plunging 26%

Apr 18

PhiChem Corporation (SZSE:300398) Stock Rockets 29% But Many Are Still Ignoring The Company

Mar 04

Returns On Capital Signal Tricky Times Ahead For PhiChem (SZSE:300398)

Feb 26

CEO

Robin Su (43 yo)

4yrs

Tenure

CN¥2,731,100

Compensation

Mr. Bin Su, also known as Robin, serves as Vice Chairman and General Manager of PhiChem Corporation. He served as Chiet Financial Officer, Director and Board Secretary at Shanghai Phichem Material Co., Lt...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Jinshan Zhang	Founder	no data	CN¥828.40k	0.82% CN¥ 51.2m
Bin Su	Vice Chairman & GM	4yrs	CN¥2.73m	0.14% CN¥ 8.4m
Xiaocheng Li	Chief Financial Officer	5.3yrs	CN¥1.05m	0.0049% CN¥ 306.2k
Lu Chun	Non-Independent Director & Deputy GM	no data	CN¥2.37m	0.069% CN¥ 4.3m
Shu Guo Song	Deputy GM & Director	no data	CN¥2.67m	no data
Song Cao	Board Secretary	5.3yrs	CN¥1.06m	0.0054% CN¥ 340.5k
Xiaosheng Qiu	Deputy General Manager	no data	CN¥1.21m	0.030% CN¥ 1.9m

4.6yrs

Average Tenure

45yo

Average Age

Experienced Management: 300398's management team is considered experienced (4.6 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Jinshan Zhang	Founder	no data	CN¥828.40k	0.82% CN¥ 51.2m
Bin Su	Vice Chairman & GM	no data	CN¥2.73m	0.14% CN¥ 8.4m
Lu Chun	Non-Independent Director & Deputy GM	6.8yrs	CN¥2.37m	0.069% CN¥ 4.3m
Shu Guo Song	Deputy GM & Director	no data	CN¥2.67m	no data
Zhijin Wang	Independent Director	7.2yrs	no data	no data
Shuai Yan	Chairman of the Supervisory Committee	no data	no data	no data
Deqing Meng	Non-Independent Director	1.1yrs	no data	no data
Bin Tu	Independent Director	1.1yrs	no data	no data
Wubin Li	Non-Employee Supervisor	1.1yrs	no data	no data
Zhonghui Tang	Independent Director	1.1yrs	no data	no data
Xiaoliang Shen	Independent Director	1.1yrs	no data	no data

1.1yrs

Average Tenure

46yo

Average Age

Experienced Board: 300398's board of directors are not considered experienced ( 1.1 years average tenure), which suggests a new board.

PhiChem Management

Management criteria checks 1/4

Key information

Recent management updates

PhiChem Corporation, Annual General Meeting, May 21, 2024

High number of new directors

Insufficient new directors

Insufficient new directors

PhiChem Corporation, Annual General Meeting, Apr 20, 2022

Insufficient new directors

Recent updates

First quarter 2024 earnings released: EPS: CN¥0.11 (vs CN¥0.14 in 1Q 2023)

PhiChem Corporation, Annual General Meeting, May 21, 2024

PhiChem Corporation (SZSE:300398) Might Not Be As Mispriced As It Looks After Plunging 26%

Investor sentiment deteriorates as stock falls 16%

PhiChem Corporation to Report Q1, 2024 Results on Apr 29, 2024

Investor sentiment deteriorates as stock falls 15%

Investor sentiment improves as stock rises 18%

PhiChem Corporation (SZSE:300398) Stock Rockets 29% But Many Are Still Ignoring The Company

Returns On Capital Signal Tricky Times Ahead For PhiChem (SZSE:300398)

Investor sentiment deteriorates as stock falls 16%

PhiChem Corporation to Report Fiscal Year 2023 Results on Mar 30, 2024

Price target decreased by 10.0% to CN¥18.85

Investor sentiment improves as stock rises 18%

New minor risk - Share price stability

Third quarter 2023 earnings released: EPS: CN¥0.069 (vs CN¥0.13 in 3Q 2022)

Price target decreased by 12% to CN¥20.94

Second quarter 2023 earnings released: EPS: CN¥0.19 (vs CN¥0.22 in 2Q 2022)

New minor risk - Dividend sustainability

High number of new directors

PhiChem Corporation Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 02 June 2023

First quarter 2023 earnings released: EPS: CN¥0.14 (vs CN¥0.27 in 1Q 2022)

Price target decreased to CN¥19.50

Insufficient new directors

Consensus EPS estimates fall by 18%

Third quarter 2022 earnings released: EPS: CN¥0.13 (vs CN¥0.20 in 3Q 2021)

Second quarter 2022 earnings released: EPS: CN¥0.22 (vs CN¥0.20 in 2Q 2021)

PhiChem Corporation Announces Cash Dividend, Payable on 16 June 2022

PhiChem Corporation (SZSE:300398) announces an Equity Buyback for CNY 100 million worth of its shares.

Insufficient new directors

PhiChem Corporation Approves Final Cash Dividend for the Year 2021

Consensus EPS estimates increase by 20%

Full year 2021 earnings: EPS and revenues exceed analyst expectations

PhiChem Corporation, Annual General Meeting, Apr 20, 2022

Insufficient new directors

PhiChem Corporation Proposes Final Cash Dividend for the Year 2021

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS CN¥0.20 (vs CN¥0.12 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.20 (vs CN¥0.12 in 2Q 2020)

Shanghai Phichem Material Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2020, Payable on 31 May 2021

First quarter 2021 earnings released: EPS CN¥0.13 (vs CN¥0.10 in 1Q 2020)

Shanghai Phichem Material Co., Ltd. Proposes Cash Dividend for the Year 2020

Shanghai Phichem Material Co., Ltd., Annual General Meeting, Apr 07, 2021

Full year 2020 earnings released: EPS CN¥0.45 (vs CN¥0.50 in FY 2019)

Shanghai Phichem Material Co., Ltd. to Report Fiscal Year 2020 Results on Mar 18, 2021

Investor sentiment deteriorated over the past week

New 90-day low: CN¥16.20

New 90-day low: CN¥17.90

Shanghai Phichem Material Co., Ltd. announced that it expects to receive CNY 825 million in funding

Price target lowered to CN¥23.21

New 90-day low: CN¥18.08

Third quarter earnings released

New 90-day low - CN¥20.50

Earnings released

Shanghai Phichem Material Co., Ltd. to Report First Half, 2020 Results on Aug 20, 2020

CEO

Tenure

Compensation

Leadership Team

Average Tenure

Average Age

Board Members

Average Tenure

Average Age